Masimo Corporation (MASI)

Masimo Corporation (NASDAQ:MASI ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM EDT Company Participants Micah Young - Chief Financial Officer Catherine Szyman - CEO & D...

LRN, RL, ATRO, MASI and BYD have been added to the Zacks Rank #1 (Strong Buy) List on September 4, 2025.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Post Holdings, Service Corporation International, TAL Education Group, Masimo and Okta.

Masimo (MASI) could produce exceptional returns because of its solid growth attributes.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading tec...

MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.

IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.